thank Year joining and Call Medical's Quarter Rockwell Fourth Results for today you, XXXX Webcast. and you morning, Full us for Good Conference Heather. Thank and
transformative for Rockwell a year Medical. was XXXX
result achieved we reducing our fourth It focusing basis. of team's on adjusted and company's customer business to profitability in come our fundamentals. EBITDA history time processes, direct quarter, first efficiencies, for This our the commitment milestone a streamlining expenses on deep For easily. the improving doesn't an key base, is expanding
sales sales, achieved second Medical's a we guidance improve. record that margin net net to of meeting profit our financial issued product we beginning transformed the gross record or Rockwell continued record row, year for gross have significantly and health. we XXXX. in at the Bottom line, And Additionally, overall exceeding
it's for how the last Rockwell our When quarter Before results, far details to remind stagnant risk loss, was a we of XXXX the come delve at of everyone consistently generating over we've heavily fourth the were middle into million. levered I important full from being We We're NASDAQ. the annually and delisted the company's in XXXX, we're operating joined a around $XX year and revenue loss. years. X.X gross at generating
further investment we focus forward, achieve During position. Rockwell pharmaceutical to and and revenue-generating financial stronger our on business, and our and in of short- quarter programs a for capital-intensive going stable efforts growing the pause profitability potential and determine that the third value we business XXXX, in long-term more would our development evaluated put
we to consider our achieve revenue-generating and sustained a then gave that profitability value, flow achieve efforts, Fast today, we higher as that business, of guidance we XXXX develop to broader successfully investments portfolio would to turn, result of these forward and longer-term that In plan. we opportunities in we expected are against in executing products. once cash a profitability from
over second $XX over XXXX. reported year gross in in XXXX. in for million generating of reported XXXX in profit We first million $X We XXXX X record $X a in now sales record and and row, now in net million approximately years row, net million the over $XX sales sales in net a generating
profitability achieved fourth both We securing completed of XXXX quarter number multiyear of expanded improved X geographic manufacturing the minimums. guidance. in in acquisitions, and supply product We our agreements we ahead EBITDA adjusted of with domestically internationally, an footprint, We agreements our customer and basis processes. and efficiencies on renegotiated a significantly
realized These XXXX gross improvements in are and increase was from a improved significant in XX% which history, being X% the loss through minus gross our X% XXXX, a in an Rockwell's improvement highest margin, XXXX. in of from
put the to in it against and fourth execute and continues the bottom our to of continuing top strategy we XXXX, a impact quarter on forth are We line. have that direct
will trajectory and this beyond. in XXXX that believe We continue
our every At market with disease. this you fortify purposely working to time to continue solutions are presented day life-sustaining our positively to XXXX. we our year, end-stage anticipated last for kidney ensure We hemodialysis patients share milestones and with impact
with We plan on agreements long-term our optimize preferred new plan to customers business with add by geographies. focus We into agreements to customers with commercially growing economics. expanding new and supply existing
and to we more reducing to expenses our our our drive business would company debt We financially to plan profitability we focus find believe reduce continue condition operating that financial most further put efficiently. seek expected a stable the continue our and more and to ways We our position. to in to on ways stronger, to achieve and business enhance critically,
we milestones morning, that these we growth corporate continued issued the we this am pleased and the and set by share results XXXX, evidenced accomplished beyond. to stage for all have believe in As for of XXXX I we
and comprised net fourth we sales the concentrates sales. over increase hemodialysis of generated in same net XX% which of $XX.X sales increase record XX% was period product net This the represented a million, product quarter XXXX. XXXX, entirely in of sales During a in
agreement. remaining record Wanbang product The the and driven the the year-over-year, of XX% was the recognition row of related was sales revenue sales million, generated related distribution revenue sales Baxter net for $XX.X in XXXX, $XX.X recognition by a second a of the and to increase sales net deferred termination net of deferred to agreement delta we year of net In product between which million.
net million and in X% which be we product million net digits. XX% anticipate will we to high that sales, XXXX. of growth we In be over single concentrates comprised between that project and $XX mid- and the product XXXX sales will sales representing sales net will between to hemodialysis grow beyond, continue In project in XXXX, XXX% $XX
Evoqua XXXX, which noted Rockwell pricing distribution concentrates is our integrated at quarter loss, also which Rockwell which our very last rightsize into and on and supported negotiate on in call, as Medical acquisition by July with were directly also through XXXX, we opportunities. focused by from of is identifying, historically during our reacquisition evidenced assets pursuing our being is Baxter our to a products, has This ability in the on minimums achieving of sold our growth of we from the of agreements This multiyear acquisition customers. evidenced fourth XXXX. the with successfully the hemodialysis rights
adding expanded in purchasing base. market hemodialysis States, X,XXX by approximately our footprint to The United facilities our customer concentrates the acquisition Evoqua new
in States, clinics As hospitals. a outpatient result, Rockwell and now dialysis purchasing services the approximately all United X/X including facilities of
an Rockwell which amended restated with now that United States. supplier into liquid bicarbonate concentrates our note and purchase leading agreement, also December Furthermore, entered we to it Under largest extend XXXX extended another products. our include could the hemodialysis of the agreement In our increase. increase is agreement hemodialysis concentrates December the through is price a another significant this and to XXXX, customer. is for amended agreement important for goes term take realizing products year, right Rockwell through in the The corresponding and XXXX, largest price this would has customer
customer Throughout in construct our continue to purchase renegotiate addition, impact benefit will to them we XXXX, number line. on inherent price increases the We Rockwell's reflects agreements, and offer a a which meaningful long-term product In patients. included purchasing supply commitments. of arrangements top such products and agreements significant minimum these signed believe have way and that we adjustments continue with a our bottom
across products is to we commercial leading actively internationally of global our hemodialysis States of and as Our concentrates. pursue continue team a the United selling becoming vision supplier our
Another joining money were gross margin. concentrates my business Rockwell, hemodialysis products to our valuing business. our Prior is key important that's we metric losing on for
gross XXXX, Today, margin the minus loss our reported that was XX%. As X%. quarter before, fourth I was we noted for XXXX of in gross
will the in and manufacturing project be In margin gross our pricing efficiencies our XXXX, margin gross will our products. XX% XX% continue improve between We or to and XX% gross is to continue in improve better margin a expenses, by improved approximately of XX%. that higher of XXXX and beyond. projected by will of driven to delivery will result project be and reach which in reduced latter We as and XXXX
the Through strategy, expanded our purposeful we of manufacturing improved value execution are capabilities. and of unlocking automated processes our
ahead indicator EBITDA XXXX of basis, was believe turned profitability achieving in milestone this business fourth that an company's history previously has our a key and time Rockwell clear guidance. quarter on issued first our in is the adjusted We Another for our of the corner. the
Rockwell unforeseen supplier all expect foreseeable the leading become to events, the is hemodialysis future. global be to vision Independent we should concentrates. profitable of of any continue Rockwell's for
and around better clinics put and performance so patients, drive improve to growth We serve further continue to centers can in Rockwell more medical our a we position the major world.
for that growing our direction and that turn pre-COVID and As which pointing of more treatments in focus our census concentrates. in number as reported are patient to dialysis on we there and XXXX favorably a returning are hemodialysis business. are Fresenius need growing at continue look Rockwell's factors a we beyond, therefore, to DaVita levels, Both represents
Our customers. expand commercial base team to is well ways add to customer as as our business new existing our pursuing aggressively within
to on arrangements. expect We customer new soon some have announcements
look United presence finally, generating actively And to opportunities that the a establish portion we to business. pursuing our accretive continue States. the immediately for revenue significant be more would We acquisition western more and ways of to in are
we improve distribution other and manufacturing through to objectives. additional infrastructure to addition our business opportunities solutions business capabilities, to and enhancing optimize and development technology our provided capabilities our the include continuing processes modernization financial next our completing Over the our strategic months, of XX to the guidance today, corporate expanded support objectives in automated
to results our for over period. With will turn expand financial that, Jesse? Jesse the reporting the I on call now to
